Doctors expect Boston Scientific to lead PFA race, survey finds
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Mena FN4d
Global Interventional Oncology Market To Reach $6.862 Billion By 2032, Growing At A 9.07% CAGR
Medtronic introduced a next-generation cryoablation system designed for enhanced tumor targeting and patient outcomes. Statistical Insights .Approximately 20 million new cancer cases were reported ...
The Motley Fool6d
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends
Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...
Cryoablation Devices Market To Hit USD 1295.34 Mn By 2032, Driven By Growing Demand For Minimally Invasive Treatments
Cryoablation Devices market set for 10.26% CAGR growth from 2024-2032, fueled by rising cancer and cardiovascular disease prevalence. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email us here Visit ...
Seeking Alpha2d
BSX Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and ...
Yahoo Finance3d
Medtronic plc (MDT)
Pre-market: 6:19:53 am GMT-5 ...
medtechdive2d
Medical Devices
The Office of Management and Budget rolled back a memo halting federal funding that caused widespread confusion and alarm. But “this is NOT a rescission of the federal funding freeze,” Trump’s top ...